久久婷婷国产综合精品,久久久久久久性潮,换脸国产av一区二区三区,韩国精品一区二区三区无码视频 ,久久久久成人精品无码

  • FDA permits marketing of first non-drug treatment for ADHD pharmatimes
    April 24, 2019
    The US Food and Drug Administration (FDA) has permitted marketing for the Monarch external Trigeminal Nerve Stimulation (eTNS) System, a new medical device to treat attention deficit hyperactivity disorder (ADHD).

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194
+86 15021993094

PharmaSources Customer Service